胺作为耐火性癌症疼痛的辅助疗法:一个案例报告
Jessica B Emshoff1, Kolby Verrona2, Ashley Conger1
1University Hospitals Portage Medical Center, Northeast Ohio Medical University College of Pharmacy, Ravenna, Ohio, USA.
Journal of pain & palliative care pharmacotherapy
|August 11, 2025
概括
低剂量的胺在标准阿片类药物治疗失败时,为管理耐药癌症疼痛提供了一个有希望的选择. 这种N-甲基-D-酸盐 (NMDA) 受体对抗剂可能会改善晚期癌症患者的生活质量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
背景情况:
- 晚期癌症疼痛是一个重大的临床挑战,通常耐受常规阿片类药物治疗.
- 耐火性癌症疼痛导致缓解不足或无法忍受的副作用,需要替代治疗.
- 阿片类药物耐受性和过敏症可以使晚期癌症患者的疼痛管理复杂化.
研究的目的:
- 审查胺的药理性质作为耐火性癌症疼痛的辅助疗法.
- 提出一个关于在患有晚期,阿片类药物耐药性癌症的患者中使用胺的病例报告.
- 突出凯胺在息护理中的治疗潜力和临床影响.
主要方法:
- 对胺的药理学进行审查,重点关注其作为N-甲基-D-酸盐 (NMDA) 受体对手的作用.
- 一个临床案例的介绍,详细介绍了在患有耐火性癌症的患者中服用胺的情况.
- 讨论胺的疗效,安全性和息护理环境中的影响.
主要成果:
- 胺,一个NMDA受体对手,表现出独特的止痛特性.
- 低剂量,亚麻醉性胺可以有效地管理严重的,难以治愈的疼痛.
- 案例报告说明了胺胺在解决阿片类药物耐受性和高症方面的潜力.
结论:
- 氨酸显示治疗潜力作为耐火性癌症疼痛的辅助治疗.
- 亚麻醉式胺可以改善晚期癌症患者的生活质量.
- 需要进一步调查胺在息性疼痛管理中的作用.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Parenteral Anesthetics: Overview
198
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
198
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
322
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
322
Analgesia and Pain Management
791
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
791
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
443
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
443


